IL9 and neoplasm: Moreover, Th9/Th22 correlation was negative in EOCRC cohort, suggesting that IL-9-driven inflammatory signals may help restrain IL-22-mediated STAT3 activation and tumor-promoting self-renewal pathways (62, 74).